U.S. Medical Equipment Stock News

As U.S. markets experience weekly losses amid rising Treasury yields and economic uncertainty, investors are increasingly on the lookout for stocks that may be undervalued relative to their intrinsic worth. In this environment, identifying companies like Arthur J. Gallagher and others that could be priced below their estimated value can offer potential opportunities for those looking to navigate the current financial landscape effectively.

Indonesia's renewable energy market is on a significant growth trajectory, fueled by policy support, declining technology costs, and rising corporate demand. The market is projected to grow from 15.97 gigawatts in 2025 to 37.32 gigawatts by 2031, registering a CAGR of 15.20% from 2026 to 2031. As the government balances climate goals with economic development, initiatives like President Prabowo Subianto's inauguration of 37 electricity projects underscore state commitment to enhancing grid...

As U.S. markets navigate a landscape of rising Treasury yields and uncertainty surrounding Federal Reserve policies, investors are keenly observing insider activities as a potential indicator of confidence in company growth prospects. In this climate, stocks with high insider ownership may signal strong alignment between management and shareholders, which can be particularly appealing when market conditions are volatile.

As the U.S. stock market faces a challenging period with major indexes posting weekly losses and Treasury yields reaching a four-month high, investors are keenly observing potential opportunities in various sectors. Penny stocks, often associated with smaller or newer companies, remain an intriguing area for those seeking growth prospects outside of the mainstream market giants. Despite being considered somewhat niche today, penny stocks can still offer significant potential when backed by...

As the U.S. market faces headwinds with major indexes posting weekly losses and Treasury yields reaching a four-month high, investors are keenly observing how these dynamics impact small-cap stocks, which often feel the effects of economic shifts more acutely. In such a climate, identifying undiscovered gems requires focusing on companies with strong fundamentals and growth potential that can weather broader market uncertainties.

As the U.S. markets navigate recent fluctuations with major indexes posting weekly losses amid rising Treasury yields, investors are keenly observing the Federal Reserve's next moves and their potential impact on interest rates. In this environment of uncertainty, dividend stocks can offer a sense of stability and income generation, making them an attractive consideration for those looking to balance growth with consistent returns.

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

You may think that with a price-to-sales (or "P/S") ratio of 2.4x Lifecore Biomedical, Inc. ( NASDAQ:LFCR ) is a stock...

Educational Development Corporation's ( NASDAQ:EDUC ) robust recent earnings didn't do much to move the stock. We...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Biglari Holdings Inc. ( NYSE:BH.A ) shareholders have had their patience rewarded with a 36% share price jump in the...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...

Shareholders might have noticed that State Street Corporation ( NYSE:STT ) filed its annual result this time last week...

Soft earnings didn't appear to concern Jabil Inc.'s ( NYSE:JBL ) shareholders over the last week. We think that the...

In December 2025, Halozyme Therapeutics announced a global collaboration and exclusive license agreement granting Takeda access to its ENHANZE drug delivery technology, including rights to use recombinant human hyaluronidase PH20 with vedolizumab for inflammatory bowel disease, in exchange for an upfront payment, potential milestones, and low- to mid-single-digit royalties. This deal extends ENHANZE into a widely used biologic therapy for Crohn’s disease and ulcerative colitis, potentially...

Lakeland Financial Corporation recently announced a 4% increase in its quarterly cash dividend to US$0.52 per share for the first quarter of 2026 and, on January 14, 2026, promoted Donald J. Robinson-Gay to Executive Vice President and Chief Credit Officer of Lake City Bank. Together, the higher dividend and elevation of a seasoned credit leader highlight management’s focus on disciplined balance sheet management and robust credit oversight. We’ll now examine how the dividend increase and...

What is driving fresh interest in Eastern Bankshares? Recent upward revisions to earnings per share estimates for Eastern Bankshares (EBC), along with forecasts for higher quarterly earnings and revenue, have put the stock on the radar for investors who are watching expectations. Analysts are currently looking for a 20.6% year over year increase in earnings and a 25.1% rise in revenue for the upcoming quarter. Those projections have been adjusted higher over the past month. See our latest...

TFS Financial (TFSL) is drawing fresh attention after adopting Heron Broker Suite, which automates over 4,000 monthly credit decisions and removes the need for two full time data entry roles. See our latest analysis for TFS Financial. The latest share price of $14.15 comes after relatively steady gains, with a 90 day share price return of 6.55% and a 1 year total shareholder return of 22.53%. This suggests momentum has been building as investors weigh operational efficiencies from Heron...

Analyst forecasts around Banner (BANR) have become a key focus for investors, with expectations for quarterly earnings of $1.46 per share and revenue of $170.27 million guiding sentiment ahead of the next report. See our latest analysis for Banner. At a share price of US$64.87, Banner has seen mixed momentum, with a 7 day share price return of 1.57% and a 90 day share price return of 2.90%. The 1 year total shareholder return of a 4.59% decline contrasts with a 3 year total shareholder return...

BMO Capital’s Juan C. Sanabria recently reiterated a Buy rating on Ventas, while Goldman Sachs initiated coverage with its own Buy recommendation, reinforcing strong analyst confidence in the healthcare REIT. These endorsements from major investment banks add further weight to an already bullish Street consensus, highlighting how analyst views can shape expectations for Ventas’ longer-term earnings outlook and risk profile. Now we’ll explore how this fresh wave of bullish analyst coverage...

Urban Outfitters (URBN) is back in focus after reporting a 9% rise in total net sales for the holiday period and 11% growth for the eleven months ended December 31, 2025, versus 2024. See our latest analysis for Urban Outfitters. Despite the solid holiday sales update and ongoing interest in Nuuly and FP Movement, the 1 month share price return of Urban Outfitters is a 14.57% decline, while the 1 year total shareholder return is 26.30%. This suggests that recent momentum has cooled compared...

Recent bullish analyst actions on Core Scientific (CORZ), including a maintained Buy rating from Craig-Hallum and a new upgrade to Buy from BTIG, have drawn fresh attention to the crypto mining stock’s performance. See our latest analysis for Core Scientific. Those bullish calls arrive as Core Scientific’s 1-month share price return of 21.09% and 7-day share price return of 8.07% suggest building momentum. At the same time, the year-to-date share price return of 18.14% and 1-year total...

BharathCloud has appointed Jones Lang LaSalle (JLL) as its exclusive advisory partner to support the buildout of AI-ready sovereign cloud infrastructure across major Indian cities and select international locations, including expansion into Tier-II and Tier-III markets. This places JLL at the center of a technologically complex, infrastructure-heavy rollout in edge cloud and data center real estate, potentially broadening its role in digital economy projects. We’ll now examine how JLL’s...

Lennar recently reported mixed fourth-quarter fiscal 2025 results, with total revenue exceeding expectations but adjusted earnings falling short amid a challenging US housing market. The company’s outlook for first-quarter fiscal 2026, calling for lower deliveries, average selling prices, and gross margins, highlights its emphasis on cost discipline and affordability to support longer-term housing demand. We’ll now explore how Lennar’s cautious guidance on deliveries and margins may reshape...